All pharmaceutical products must be registered with the Drug Control Authority (DCA) following a quality, safety and efficacy evaluation process by the National Pharmaceutical Regulatory Agency (NPRA), MOH before it can be marketed in Malaysia. NPRA has been recognised by the World Health Organizati...
19 Disember 2020 - Kementerian Kesihatan (KKM) memberi jaminan negara bakal memiliki sekurang-kurang 50 peratus jumlah vaksin COVID-19 diperlukan, termasuk melalui pemeteraian perjanjian pembelian dijadualkan pada Isnin ini.
Menteri Kesihatan, Dato' Sri Dr Adham Baba, berkata perjanjian pembelian 1...
KLUANG, 19 Dis 2020 -- Kerajaan akan memeterai perjanjian dengan syarikat farmaseutikal AstraZeneca dari United Kingdom pada Isnin ini bagi pembelian vaksin COVID-19 bagi memenuhi keperluan imunisasi 20 peratus rakyat Malaysia.
Menteri Kesihatan Datuk Seri Dr Adham Baba berkata ia merupakan perjanj...
10 December 2020 – MOH participated in the International Health Regulation (IHR) Exercise Crystal 2020 involving Member States, areas and territories of the WHO Western Pacific Region. The participants included representatives from the Disease Control Division, Medical Development Division, Pharmacy...
TANGKAK, 13 Dis -- Kerajaan bercadang meningkatkan pembelian vaksin COVID-19 agar dapat menampung keperluan imunisasi hingga 70 peratus rakyat berbanding kuantiti asal sebanyak 30 peratus, kata Perdana Menteri Tan Sri Muhyiddin Yassin. Beliau berkata ini kerana ada negara yang sudah membeli vaksin i...